enzastaurin has been researched along with Lymphoma, Follicular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreyling, M; Flinn, I; Flora, D; Hamid, O; Hermann, R; Hsi, ED; Lin, BK; Myrand, SP; Nguyen, TS; Schwartzberg, L; Shi, P | 1 |
| Ogura, M | 1 |
1 review(s) available for enzastaurin and Lymphoma, Follicular
| Article | Year |
|---|---|
[Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Gene Targeting; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Nitrogen Mustard Compounds; Prednisone; Prognosis; Purine Nucleosides; Pyrimidinones; Risk; Rituximab; Salvage Therapy; Sirolimus; Transplantation, Autologous; Vincristine | 2008 |
1 trial(s) available for enzastaurin and Lymphoma, Follicular
| Article | Year |
|---|---|
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Female; Humans; Indoles; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Protein Kinase C beta; Protein Kinase Inhibitors; Treatment Outcome | 2014 |